ID   BEAS-2B IRF1 KO
AC   CVCL_C2UN
SY   BEAS-2B-IRF1 KO; IRF1 KO BEAS-2B
DR   GEO; GSM3138806
DR   GEO; GSM3138807
DR   GEO; GSM3138808
DR   GEO; GSM3138809
DR   GEO; GSM3138810
DR   GEO; GSM3138811
DR   GEO; GSM3138812
DR   GEO; GSM3138813
DR   GEO; GSM3138814
DR   Wikidata; Q114310727
RX   PubMed=31156620;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6116; IRF1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=31156620; DOI=10.3389/fimmu.2019.01019;
RA   Panda D., Gjinaj E., Bachu M., Squire E., Novatt H., Ozato K.,
RA   Rabin R.L.;
RT   "IRF1 maintains optimal constitutive expression of antiviral genes and
RT   regulates the early antiviral response.";
RL   Front. Immunol. 10:1019.1-1019.16(2019).
//